EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment [Yahoo! Finance]
Eyepoint Pharmaceuticals (EYPT) had its price target raised by Citigroup Inc. from $31.00 to $35.00. They now have a "buy" rating on the stock.
Eyepoint Pharmaceuticals (EYPT) had its price target raised by HC Wainwright from $23.00 to $30.00. They now have a "buy" rating on the stock.
EyePoint Inc (EYPT) Q4 2025 Earnings Call Highlights: Navigating Revenue Decline Amid Promising ... [Yahoo! Finance]